You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Endometrial Cancer Consult: Optimal Management Across the Disease Continuum

  • Authors: Jubilee Brown, MD; David S. Miller, MD; Matthew Powell, MD
  • CME / ABIM MOC Released: 1/6/2023
  • Valid for credit through: 1/10/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for oncologists, obstetricians/gynecologists, surgeons, pathologists, and other healthcare professionals on the EC care team.

The goal of this activity is that the learner will be better able to tailor treatment decisions for patients with EC based upon the available evidence.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical trial data associated with treatment options for patients with EC
  • Have greater competence related to
    • Tailoring treatment decisions for patients with EC
  • Demonstrate greater confidence in their ability to
    • Select treatment for patients with EC based on patient and disease characteristics


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Jubilee Brown, MD

    Professor and Division Director of Gynecologic Oncology
    Levine Cancer Institute
    Atrium Health
    Charlotte, North Carolina

    Disclosures

    Jubilee Brown, MD, has the following relevant financial relationships:
    Consultant or advisor for: AstraZeneca; Caris; Clovis; Eisai; GSK/Tesaro
    Research funding from: Genentech; GSK/Tesaro

  • David Miller, MD

    Amy and Vernon E. Faulconer Distinguished Chair in Medical Science
    Director and Dallas Foundation Chair in Gynecologic Oncology
    Professor of Obstetrics and Gynecology
    University of Texas Southwestern Medical Center
    Dallas, Texas

    Disclosures

    David S. Miller, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie Inc.; Agenus; AstraZeneca; Asymmetric Therapeutics, LLC; Clinical Education Alliance, LLC; Eisai; Eisai Europe Limited; EMD Serono Inc; GlaxoSmithKline LLC; Immunogen; Incyte; iTeos Belgium SA; Karyopharm Therapeutics; Merck Sharp & Dohme; Myriad Genetic Laboratories Inc; Novartis; Novocure Inc; Seagen Inc; Tarveda Therapeutics
    Speaker or member of speakers bureau for: Clovis Oncology; Genentech
    Research funding from: Advenchen Laboratories; Advaxis; Aeterna Zentaris; Agenus; Akesobio; Aprea AB; AstraZeneca; EMD SERONO RESEARCH & DEVELOPMENT INST; Immunogen; Incyte Corporation; Janssen; Leap therapeutics; Mateon Therapeutics; Merck Sharp & Dohme; Millennium Pharmaceuticals; NVision; Novartis; Pfizer; Syros Pharmaceuticals; US Biotest; Regeneron; Tesaro; TRACON Pharma; Xenetic Biosciences

  • Matthew Powell, MD

    Professor, Obstetrics and Gynecology
    Chief, Division of Gynecologic Oncology
    Washington University School of Medicine
    St Louis, Missouri

    Disclosures

    Matthew Powell, MD, has the following relevant financial relationships:
    Consultant or advisor for: AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline LLC; Seagen Inc
    Research funding from: GlaxoSmithKline LLC

Editors

  • Amy Furedy, RN, OCN

    Medical Education Director, Medscape, LLC

    Disclosures

    Amy Furedy, RN, OCN, has no relevant financial relationships.

  • Yoji Yamaguchi, MA, ELS

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Yoji Yamaguchi, MA, ELS, has no relevant financial relationships.

Compliance Reviewer

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Developed through a partnership between Medscape and GOG Foundation.



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Endometrial Cancer Consult: Optimal Management Across the Disease Continuum

Authors: Jubilee Brown, MD; David S. Miller, MD; Matthew Powell, MDFaculty and Disclosures

CME / ABIM MOC Released: 1/6/2023

Valid for credit through: 1/10/2024

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Optimal Management Across the Disease Continuum: First-Line Treatment of Deficient Mismatch Repair Disease

Dr Powell reviews current treatment options and ongoing clinical trials for first-line treatment of a patient with advanced endometrial cancer.
Matthew Powell, MD

Optimal Management Across the Disease Continuum: Recurrent Deficient Mismatch Repair Disease

Dr Brown discusses treatment options for a patient with recurrent deficient mismatch repair advanced endometrial cancer.
Jubilee Brown, MD

Optimal Management Across the Disease Continuum: Recurrent Proficient Mismatch Repair Disease

Dr Miller reviews the case of a patient with recurrent proficient mismatch repair disease endometrial cancer and discusses the current treatment landscape.
David S. Miller, MD
 

Educational Impact Challenge

The goal of this activity is that the learner will be better able to tailor treatment decisions for patients with EC based upon the available evidence.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print